At ESMO 2025 in Berlin, pharmaphorum spoke with Dr Inge Marie Svane – Professor in Clinical cancer immune therapy and director of the translational research centre, Center for Cancer Immune Therapy ...

Immuno-oncology is an evolving field of study on the role of the immune system in cancer initiation and growth. This introductory module describes the purpose of the human immune system, components of ...

There are two key things to know about the new Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer from Thermo Fisher Scientific, said Ravi Gupta, vice president and general manager of Thermo ...

Abstract: Microarray image processing leads to the characterization of gene expression levels simultaneously, for all cellular transcripts (mRNAs) in a single experiment. The calculation of expression ...

Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking research in ...

AstraZeneca is extending its work with Immunai through a multiyear collaboration that aims to implement its artificial-intelligence-powered immune cell atlas in the design of the drugmaker’s clinical ...

Aug 12 (Reuters) - Pfizer (PFE.N), opens new tab said on Monday its respiratory syncytial virus (RSV) vaccine Abrysvo generated a strong immune response in a late-stage study of four groups of adults ...

According to recent study by nova one advisor, the global immuno-oncology (IO) market size was estimated at USD 43.73 billion in 2023 and is projected to hit around USD 284.29 billion by 2033, growing ...

The first study of the use of microarray patches to vaccinate children has shown that the method is safe and induces strong immune responses. The phase 1/2 randomized trial compared results from the ...

Immuno-oncology has captured the attention of researchers and pharmaceutical industries worldwide. This promising treatment at the forefront of cancer research is already reaching patients and uses ...